NEW YORK, December 14 - Rosetta Inpharmatics inaugurated Thursday a new gene
expression profiling facility in Bothell, Wash.

At the facility, researchers will use image analysis technology and
molecular biology processes to generate gene expression data for drug and
drug target discovery, the company said.

" Our new facility in Bothell will help us further our efforts in gene
expression research, and will advance our goal to develop solutions that
will accelerate and enhance the drug discovery process," said Rosetta CEO

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.